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Psychoactive substances: Position 
statement on harm reduction
The recent special session of the United Nations General Assembly on 
drugs was timely for several reasons. It is clear that the ‘war on drugs’ has 
failed – a singular focus on supply reduction does not work. Worldwide, 
there have been ongoing changes in the legal status of alcohol, tobacco, 
marijuana and other psychoactive substances or drugs, as states attempt 
to develop balanced strategies of supply reduction, demand reduction 
and harm reduction. There is increasing emphasis on the importance 
of implementing evidence-based policies to address the significant 
morbidity and mortality associated with the use of alcohol, tobacco, 
marijuana and other psychoactive substances.[1-4]
Psychoactive substances are subject to several international and national 
conventions and laws that have emphasised the importance of the ‘war on 
drugs’ and supply reduction. At the same time, it is increasingly clear that 
evidence-based, balanced policies are needed, which address the important 
differences between alcohol, tobacco, marijuana and other psychoactive 
substances or drugs.[5] The Prevention of and Treatment for Substance 
Abuse Act 70 of 2008 speaks to the National Drug Master Plan, which 
emphasises a range of strategies for addressing the excessive use of alcohol, 
tobacco, marijuana and other psychoactive substances.
Supply reduction refers to policing efforts to curb the manufacture 
and distribution of alcohol, tobacco, marijuana and other psychoactive 
substances or drugs. Demand reduction refers to preventive efforts 
to decrease their demand. Harm reduction refers to policies and 
interventions to reduce the harmful consequences of alcohol, tobacco, 
marijuana and other psychoactive substance use. Focusing on harm 
reduction does not indicate that risky behaviours in general, and the use 
of psychoactive substances or drugs in particular, are welcomed. This 
approach is based rather on the scientific evidence on what works to 
improve public health and reduce social harms when tobacco, alcohol, 
marijuana and other psychoactive substances are already being used.[6,7]
Not all psychoactive substance use is harmful, although alcohol, 
tobacco, marijuana and other psychoactive substances are associated 
with a spectrum of potential harms to individuals and to society.[5] 
Extrapolating from international knowledge, it is clear that in South 
Africa (SA) alcohol is the most harmful substance in use, in view of its 
links with physical illness, mental illness, interpersonal violence and 
crime. Tobacco is also extremely harmful to individuals and costly for 
society because of its link with lung cancer and other medical conditions. 
Marijuana has been associated with many harmful effects, as have 
a range of other substances. Therefore, evidence-based policies and 
interventions must address the individuals and communities involved, 
the drugs being consumed and the environment in which this occurs.[8]
Fortunately, growing evidence shows that specific policies and 
interventions can reduce the potential harms associated with the 
continued use of psychoactive substances.[6,7] For example, there is 
considerable evidence that brief psychotherapies are useful for treating 
sufferers from alcohol, tobacco, marijuana and other drug dependence. 
Primary care clinicians should screen for abuse and provide evidence-
based interventions where indicated.[9] Other efficacious interventions 
for reducing harm in people with alcohol, tobacco, marijuana, opioid 
and other drug use include medication-assisted treatment and needle 
and syringe programmes.[10,11] Providing such interventions requires 
the work of many stakeholders; skills must be developed, medications 
and human resources made available, and health systems strengthened.
Recommendations
• The National Drug Master Plan emphasises the importance of 
an integrated approach to supply reduction, demand reduction 
and harm reduction strategies for combating alcohol, tobacco, 
marijuana and other psychoactive substance use and abuse in SA. 
For any substance, the balance between these three strategies and the 
approach taken should be evidence-based.
• Data from other countries show that alcohol causes the most 
individual and societal harm. It is therefore essential to put particular 
efforts into implementing evidence-based policies and interventions 
for alcohol harm reduction. This should address upstream drivers of 
alcohol use, as well as prevention and intervention.
• Efforts to reduce harm have been poorly resourced in SA and, given 
the enormous profits of the liquor industry, there is a need and 
obligation for its greater involvement in local harm reduction efforts.
• Local school survey data suggest high rates of experimentation 
with alcohol, tobacco, marijuana and other drugs during early 
adolescence. Evidence-based interventions, including a strong focus 
on harm reduction, are needed in this age group, which comprises a 
large proportion of South Africans.
• There is little evidence that focusing on supply reduction via 
criminalisation is effective in reducing alcohol, tobacco, marijuana 
and other substance abuse. There are insufficient data showing that 
the commercialisation of such entities is safe, particularly when it is 
not accompanied by rigorous supply, demand and harm reduction 
strategies.
• Evidence-based approaches that reduce harm from continued and 
chronic use of alcohol, tobacco, marijuana and other substances 
(particularly among vulnerable groups such as adolescents and 
people with mental disorders) deserve greater attention and 
additional resources. These include psychotherapy and medication-
assisted therapy for individuals, and addressing the structural drivers 
of continued psychoactive substance use.
• Mental, neurological and substance use disorders contribute 
significantly to SA’s burden of disease. There must be more research 
attention and a greater focus of clinical resources on this area.
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